Flywheel vs Veeva

Amazon AI Tools Launch, Brands Cheer Review Requests

Amazon's unBoxed event showcased AI-driven advertising tools like Amazon Ads Agent, Full-Funnel Campaigns, and conversational analytics, but advertisers were more excited about Review Requests, which tripled product reviews in testing. Amazon also launched Branded Conversations within Alexa for Shopping and rebranded its DSP to DVA+. Meanwhile, industry developments include Apple's stricter tracking protections in WebKit, blocking The Trade Desk's domain and affecting ad delivery, and OpenWeb's receivership due to a $20 million loan default. These events highlight a trend towards onsite ad formats and the rise of AI chat interfaces as ad surfaces. Bain & Company and eMarketer survey confirms onsite formats as top growth drivers for retail media networks.

• Amazon launched Review Requests, which generated three times more product reviews in testing, and opens in US beta in late October 2026.
• Amazon rebranded its DSP as DVA+ and introduced Branded Conversations for advertising in Alexa for Shopping.
• Apple blocked The Trade Desk's ad serving domain in WebKit, affecting 34% of US web traffic and 21.7% worldwide.

IQVIA Expands Veeva Partnership with Clinical Operations Applications

IQVIA and Veeva Systems announced an expansion of their partnership, with IQVIA selecting Veeva CTMS, eTMF, Study Startup, and Site Connect as enterprise standard applications for its clinical development studies. This extends the previously announced EDC partnership. The collaboration aims to increase trial speed and efficiency, strengthen site centricity, and improve decision-making for clinical research customers. All Veeva clinical solutions will also be available through IQVIA for sponsors seeking a full Veeva technology stack. Executives from both companies emphasized the benefits of integrated technologies and customer flexibility in choosing EDC, RTSM, and eCOA solutions. The announcement was made on October 13, 2026, ahead of the Veeva R&D and Quality Summit scheduled for October 20-21 in Boston.

• IQVIA selected Veeva CTMS, eTMF, Study Startup, and Site Connect as enterprise standard applications.
• Partnership expansion extends the previously announced EDC partnership.
• All Veeva clinical solutions will be available through IQVIA for sponsors.

Servier Adopts Veeva OpenData Globally for AI

Servier, a French pharmaceutical company, is standardizing its customer reference data across more than 80 countries with Veeva OpenData, part of Veeva Data Cloud. This initiative builds on Servier's use of Veeva Link Key People and aims to create an AI-ready data foundation by harmonizing fragmented data silos. The centralized data will help commercial and medical teams gain faster insights and improve efficiency. Liam Hanrahan, Director of Global Operations Excellence at Servier, highlighted that the centralized data will improve processes and enable a semantic layer for better engagement with key healthcare professionals. Veeva's president, Kilian Weiss, emphasized that 89% of AI initiatives fail due to data challenges, and Servier's data-first approach demonstrates industry leadership. The adoption replaces fragmented silos and ensures consistency for scaling advanced analytics and AI.

• Servier standardizes customer reference data with Veeva OpenData across more than 80 countries.
• The initiative builds on Servier's use of Veeva Link Key People.
• Veeva OpenData is part of Veeva Data Cloud, which also includes Veeva Link and Veeva Compass.

New Veeva Study Builder Agent to Configure Clinical Studies in as Little as One Day

Veeva announces a new Study Builder Agent that can configure clinical studies in as little as one day, along with other updates including another Top 20 biopharma choosing Vault CRM and the introduction of Falcon Router for agentic triage.